Product Code: ETC13244898 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Arthritis Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Arthritis Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Arthritis Market Revenues & Volume, 2021 & 2031F |
3.3 North America Arthritis Market - Industry Life Cycle |
3.4 North America Arthritis Market - Porter's Five Forces |
3.5 North America Arthritis Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Arthritis Market Revenues & Volume Share, By Rheumatoid Drug Type, 2021 & 2031F |
3.7 North America Arthritis Market Revenues & Volume Share, By Rheumatoid Treatment, 2021 & 2031F |
3.8 North America Arthritis Market Revenues & Volume Share, By Rheumatoid Diagnosis, 2021 & 2031F |
3.9 North America Arthritis Market Revenues & Volume Share, By Osteoarthritis Type, 2021 & 2031F |
3.10 North America Arthritis Market Revenues & Volume Share, By Osteoarthritis Diagnosis, 2021 & 2031F |
3.11 North America Arthritis Market Revenues & Volume Share, By Osteoarthritis Treatment, 2021 & 2031F |
3.12 North America Arthritis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.12 North America Arthritis Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 North America Arthritis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Arthritis Market Trends |
6 North America Arthritis Market, 2021 - 2031 |
6.1 North America Arthritis Market, Revenues & Volume, By Rheumatoid Drug Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Arthritis Market, Revenues & Volume, By Biologics, 2021 - 2031 |
6.1.3 North America Arthritis Market, Revenues & Volume, By Non-Biologics, 2021 - 2031 |
6.1.4 North America Arthritis Market, Revenues & Volume, By Steroids, 2021 - 2031 |
6.1.5 North America Arthritis Market, Revenues & Volume, By Analgesics, 2021 - 2031 |
6.1.6 North America Arthritis Market, Revenues & Volume, By Glucocorticoids, 2021 - 2031 |
6.1.7 North America Arthritis Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 North America Arthritis Market, Revenues & Volume, By Rheumatoid Treatment, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Arthritis Market, Revenues & Volume, By Synovectomy, 2021 - 2031 |
6.2.3 North America Arthritis Market, Revenues & Volume, By Tendon Repair, 2021 - 2031 |
6.2.4 North America Arthritis Market, Revenues & Volume, By Joint Fusion, 2021 - 2031 |
6.2.5 North America Arthritis Market, Revenues & Volume, By Symptomatic Treatment, 2021 - 2031 |
6.2.6 North America Arthritis Market, Revenues & Volume, By Intermediate Corticosteroid Therapies, 2021 - 2031 |
6.2.7 North America Arthritis Market, Revenues & Volume, By DMARD Therapies, 2021 - 2031 |
6.3 North America Arthritis Market, Revenues & Volume, By Rheumatoid Diagnosis, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Arthritis Market, Revenues & Volume, By C.R.P. Test, 2021 - 2031 |
6.3.3 North America Arthritis Market, Revenues & Volume, By C.C.P., 2021 - 2031 |
6.3.4 North America Arthritis Market, Revenues & Volume, By E.S.R. Test, 2021 - 2031 |
6.4 North America Arthritis Market, Revenues & Volume, By Osteoarthritis Type, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 North America Arthritis Market, Revenues & Volume, By Hip, 2021 - 2031 |
6.4.3 North America Arthritis Market, Revenues & Volume, By Spinal, 2021 - 2031 |
6.4.4 North America Arthritis Market, Revenues & Volume, By Knee, 2021 - 2031 |
6.4.5 North America Arthritis Market, Revenues & Volume, By Foot and Ankle, 2021 - 2031 |
6.4.6 North America Arthritis Market, Revenues & Volume, By Shoulder, 2021 - 2031 |
6.4.7 North America Arthritis Market, Revenues & Volume, By Hand, 2021 - 2031 |
6.5 North America Arthritis Market, Revenues & Volume, By Osteoarthritis Diagnosis, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 North America Arthritis Market, Revenues & Volume, By Imaging, 2021 - 2031 |
6.5.3 North America Arthritis Market, Revenues & Volume, By Joint Fluid Analysis, 2021 - 2031 |
6.5.4 North America Arthritis Market, Revenues & Volume, By Others, 2021 - 2031 |
6.6 North America Arthritis Market, Revenues & Volume, By Osteoarthritis Treatment, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 North America Arthritis Market, Revenues & Volume, By Medication, 2021 - 2031 |
6.6.3 North America Arthritis Market, Revenues & Volume, By Drugs, 2021 - 2031 |
6.6.4 North America Arthritis Market, Revenues & Volume, By Assistive Devices, 2021 - 2031 |
6.6.5 North America Arthritis Market, Revenues & Volume, By Surgery, 2021 - 2031 |
6.6.6 North America Arthritis Market, Revenues & Volume, By Therapy, 2021 - 2031 |
6.7 North America Arthritis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.7.1 Overview & Analysis |
6.7.2 North America Arthritis Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.7.3 North America Arthritis Market, Revenues & Volume, By Parenteral, 2021 - 2031 |
6.8 North America Arthritis Market, Revenues & Volume, By End-Users, 2021 - 2031 |
6.8.1 Overview & Analysis |
6.8.2 North America Arthritis Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.8.3 North America Arthritis Market, Revenues & Volume, By Specialty Clinics, 2021 - 2031 |
6.8.4 North America Arthritis Market, Revenues & Volume, By Household, 2021 - 2031 |
6.8.5 North America Arthritis Market, Revenues & Volume, By Medical Institutes, 2021 - 2031 |
6.8.6 North America Arthritis Market, Revenues & Volume, By Research Organizations, 2021 - 2031 |
6.8.7 North America Arthritis Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Arthritis Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Arthritis Market, Revenues & Volume, By Rheumatoid Drug Type, 2021 - 2031 |
7.2.1 United States (US) Arthritis Market, Revenues & Volume, By Rheumatoid Drug Type, 2021 - 2031 |
7.2.2 Canada Arthritis Market, Revenues & Volume, By Rheumatoid Drug Type, 2021 - 2031 |
7.2.3 Rest of North America Arthritis Market, Revenues & Volume, By Rheumatoid Drug Type, 2021 - 2031 |
7.3 North America Arthritis Market Revenues & Volume Share, By Rheumatoid Treatment, 2021 & 2031F |
7.3.1 United States (US) Arthritis Market, Revenues & Volume, By Rheumatoid Treatment, 2021 - 2031 |
7.3.2 Canada Arthritis Market, Revenues & Volume, By Rheumatoid Treatment, 2021 - 2031 |
7.3.3 Rest of North America Arthritis Market, Revenues & Volume, By Rheumatoid Treatment, 2021 - 2031 |
7.4 North America Arthritis Market, Revenues & Volume, By Rheumatoid Diagnosis, 2021 - 2031 |
7.4.1 United States (US) Arthritis Market, Revenues & Volume, By Rheumatoid Diagnosis, 2021 - 2031 |
7.4.2 Canada Arthritis Market, Revenues & Volume, By Rheumatoid Diagnosis, 2021 - 2031 |
7.4.3 Rest of North America Arthritis Market, Revenues & Volume, By Rheumatoid Diagnosis, 2021 - 2031 |
7.5 North America Arthritis Market, Revenues & Volume, By Osteoarthritis Type, 2021 - 2031 |
7.5.1 United States (US) Arthritis Market, Revenues & Volume, By Osteoarthritis Type, 2021 - 2031 |
7.5.2 Canada Arthritis Market, Revenues & Volume, By Osteoarthritis Type, 2021 - 2031 |
7.5.3 Rest of North America Arthritis Market, Revenues & Volume, By Osteoarthritis Type, 2021 - 2031 |
7.6 North America Arthritis Market, Revenues & Volume, By Osteoarthritis Diagnosis, 2021 - 2031 |
7.6.1 United States (US) Arthritis Market, Revenues & Volume, By Osteoarthritis Diagnosis, 2021 - 2031 |
7.6.2 Canada Arthritis Market, Revenues & Volume, By Osteoarthritis Diagnosis, 2021 - 2031 |
7.6.3 Rest of North America Arthritis Market, Revenues & Volume, By Osteoarthritis Diagnosis, 2021 - 2031 |
7.7 North America Arthritis Market, Revenues & Volume, By Osteoarthritis Treatment, 2021 - 2031 |
7.7.1 United States (US) Arthritis Market, Revenues & Volume, By Osteoarthritis Treatment, 2021 - 2031 |
7.7.2 Canada Arthritis Market, Revenues & Volume, By Osteoarthritis Treatment, 2021 - 2031 |
7.7.3 Rest of North America Arthritis Market, Revenues & Volume, By Osteoarthritis Treatment, 2021 - 2031 |
7.8 North America Arthritis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.8.1 United States (US) Arthritis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.8.2 Canada Arthritis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.8.3 Rest of North America Arthritis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.9 North America Arthritis Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.9.1 United States (US) Arthritis Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.9.2 Canada Arthritis Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.9.3 Rest of North America Arthritis Market, Revenues & Volume, By End-Users, 2021 - 2031 |
8 North America Arthritis Market Key Performance Indicators |
9 North America Arthritis Market - Export/Import By Countries Assessment |
10 North America Arthritis Market - Opportunity Assessment |
10.1 North America Arthritis Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Arthritis Market Opportunity Assessment, By Rheumatoid Drug Type, 2021 & 2031F |
10.3 North America Arthritis Market Opportunity Assessment, By Rheumatoid Treatment, 2021 & 2031F |
10.4 North America Arthritis Market Opportunity Assessment, By Rheumatoid Diagnosis, 2021 & 2031F |
10.5 North America Arthritis Market Opportunity Assessment, By Osteoarthritis Type, 2021 & 2031F |
10.6 North America Arthritis Market Opportunity Assessment, By Osteoarthritis Diagnosis, 2021 & 2031F |
10.7 North America Arthritis Market Opportunity Assessment, By Osteoarthritis Treatment, 2021 & 2031F |
10.8 North America Arthritis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10.9 North America Arthritis Market Opportunity Assessment, By End-Users, 2021 & 2031F |
11 North America Arthritis Market - Competitive Landscape |
11.1 North America Arthritis Market Revenue Share, By Companies, 2022 |
11.2 North America Arthritis Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |